Free shipping on all orders over $ 500

MBX-2982

Cat. No. M3632
MBX-2982 Structure
Synonym:

MBX2982

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 140  USD140 In stock
2mg USD 85  USD85 In stock
5mg USD 130  USD130 In stock
10mg USD 220  USD220 In stock
50mg USD 760  USD760 In stock
100mg USD 1240  USD1240 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MBX-2982 is a potent selective orally-active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the beta cell to increase insulin secretion. In addition, MBX-2982 stimulates release of the incretin GLP-1 from the gut. Treatment with MBX-2982 increased insulin, active GLP-1, and total GLP-1 during an extended MMTT. Treatment with MBX-2982 also tended to increase fasting insulin and c-peptide, and decrease fasting triglycerides. MBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion.

Customer Product Validations & Biological Datas
Source Eur J Pharmacol (2015). Figure 5. MBX-2982
Method Examining the longevity of wash-resistant cAMP responses to GPR119 agonists
Cell Lines HEK-GPR119 cells.
Concentrations 30 nM
Incubation Time 60 min
Results These data are consistent with a requirement for membrane deposition in the sustained wash-resistant effects for MBX-2982 and AZ1, but not AR-231, 453.
Chemical Information
Molecular Weight 448.54
Formula C22H24N8OS
CAS Number 1037792-44-1
Solubility (25°C) DMSO ≥ 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Gater D. IDrugs. 32nd National Medicinal Chemistry Symposium--medicinal chemistry developments for neurodegeneration, diabetes and cancer.

[2] Jones RM, et al. Expert Opin Ther Pat. GPR119 agonists for the treatment of type 2 diabetes.

Related GPR/FFAR Products
[Ala17]-MCH

[Ala17]-MCH, a MCH analogue, is a selective ligand for MCHR1 (Ki=0.16 nM) over MCHR2 (Ki=34 nM).

BigLEN(rat)

BigLEN(rat) is a potent GPR171 agonist with an EC50 of 1.6 nM.

BigLEN(mouse)

BigLEN(mouse) is a potent and selective agonist of orphan G protein-coupled receptor 171 (GPR171), with a Kd of ∼0.5 nM.

Neuropeptide EI, rat

Neuropeptide EI, rat displays functional melanin concentrating hormone (MCH)-antagonist and melanocyte-stimulating hormone (MSH) agonist activity in different behavioral paradigms.

(Phe13, Tyr19)-MCH (human, mouse, rat)

(Phe13,Tyr19)-MCH (human, mouse, rat) is a potent SLC-1 and S643b receptor ligand.

  Catalog
Abmole Inhibitor Catalog




Keywords: MBX-2982, MBX2982 supplier, GPR/FFAR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.